Equity markets delivered a mixed performance as a pause in rising oil prices offered little relief to investors already watching bond yields hover near recent highs. The divergence across global indices reflected
More
Hargreaves Lansdown, one of the UK’s largest investment platforms, regularly publishes its weekly stock market preview to help investors prepare for key events. The weekly outlook is a widely followed guide among
More
BP is closing in on a deal to sell its solar power arm to an investor consortium backed by Kuwait’s sovereign wealth fund, marking another step away from renewables. Private equity firm
More
Merck (NYSE: MRK) has unveiled a sweeping access strategy for alimatravir, an investigational once-monthly oral pill designed to prevent HIV-1 infection. The drug, also known as MK-8527, is being positioned as a
More
Novo Nordisk has escalated its legal fight against Eli Lilly, notifying a federal court of plans to seek a preliminary injunction blocking certain rival obesity drug advertisements. The Danish pharmaceutical giant filed
More
On July 23, President Trump issued a memorandum directing the U.S. Trade Representative to impose tariffs on goods from 60 economies found to have failed to ban imports made with forced labor.
More
Tom Goldstein, the Supreme Court attorney and co-founder of SCOTUSblog, has been sentenced to six years in federal prison following his conviction on tax and mortgage fraud charges. The charges stemmed from
More
Diageo (LSE: DGE) shares have endured a torrid few years, shedding more than half their value over the past three years alone. Despite that poor run, City analysts are now forecasting a
More
August has long carried a reputation as a dangerous month for stock markets, but the historical evidence tells a more complicated and nuanced story. The idea that August is reliably bad for
More
Alphabet and Tesla have long been considered bellwether stocks, their quarterly results often setting the tone for broader market sentiment across Wall Street. When two of the most closely watched companies in
More